These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7698151)

  • 1. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
    Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotargeting of urothelial cell carcinoma with intravesically administered Tc-99m labeled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Sivolapenko G; Skarlos DV; Serefoglou A; Lykourinas M; Proukakis C
    Cell Biophys; 1994; 24-25():75-81. PubMed ID: 7736542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer.
    Syrigos KN; Khawaja M; Krausz T; Williams G; Epenetos AA
    Acta Oncol; 1999; 38(3):379-82. PubMed ID: 10380831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder.
    Zorzos J; Skarlos DV; Pozatzidou P; Zizi A; Bakiras A; Koritsiadis S; Pectasidis D; Koutsioumba P; Epenetos AA; Likourinas M
    Urol Res; 1994; 22(5):323-7. PubMed ID: 7879319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas.
    Bamias A; Bowles MJ; Krausz T; Williams G; Epenetos AA
    Int J Cancer; 1993 Jul; 54(6):899-903. PubMed ID: 8335396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTechnetium-C595 radioimmunoscintigraphy: a potential staging tool for bladder cancer.
    Simms MS; Perkins AC; Price MR; Scholfield DP; Bishop MC
    BJU Int; 2001 Nov; 88(7):686-91. PubMed ID: 11890238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution.
    Zorzos J; Skarlos DV; Epenetos AA; Pectasides D; Koutsioumba P; Elemenoglou J; Bakiras A; Likourinas M; Dimopoulos K
    Urol Res; 1993; 21(6):435-8. PubMed ID: 8171767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of bladder cancer with monoclonal antibody NCRC48--a possible approach for intravesical therapy.
    Kunkler RB; Bishop MC; Green DJ; Pimm MV; Price MR; Frier M
    Br J Urol; 1995 Jul; 76(1):81-6. PubMed ID: 7648066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioimmunoimaging of bladder tumor with the intravesical administration of technetium -99m labelled monoclonal antibody].
    Li N; Yu L; Zhang C
    Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):54-6. PubMed ID: 11715544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour localization of radiolabelled monoclonal antibody in mice bearing human urinary bladder (T24) carcinoma xenografts.
    Bubeník J; Kieler J; Perlmann P; Paulie S; Koho H; Christensen B; Dienstbier Z; Koprivová H; Pospísil J; Novák F
    Folia Biol (Praha); 1985; 31(2):176-84. PubMed ID: 3894060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.
    Hughes OD; Bishop MC; Perkins AC; Frier M; Price MR; Denton G; Smith A; Rutherford R; Schubiger PA
    Eur J Nucl Med; 1997 Apr; 24(4):439-43. PubMed ID: 9096097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo localisation of human urinary bladder carcinoma xenograft in nude mice using radiolabelled monoclonal antibody.
    Yü DS; Yeh MY; Chen WL; Chang SY; Ma CP; Han SH
    Br J Urol; 1987 Jun; 59(6):540-6. PubMed ID: 3690186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma imaging with a new technetium-99m labelled antibody, LL2.
    Murthy S; Sharkey RM; Goldenberg DM; Lee RE; Pinsky CM; Hansen HJ; Burger K; Swayne LC
    Eur J Nucl Med; 1992; 19(6):394-401. PubMed ID: 1618230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin.
    Torres LA; Perera A; Batista JF; Hernández A; Crombet T; Ramos M; Neninger E; Pérez M; Sánchez EL; Romero S; Aguilar V; Coca MA; Iznaga-Escobar N
    Nucl Med Commun; 2005 Dec; 26(12):1049-57. PubMed ID: 16264350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
    J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted diagnosis and treatment of superficial bladder cancer with monoclonal antibody BDI-1.
    Yu L; Gu F; Zhang C; Xie S; Guo Y
    Chin Med J (Engl); 1998 May; 111(5):404-7. PubMed ID: 10374347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
    Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
    Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted diagnosis of bladder and ureteral carcinoma using radiolabelled BDI-1.
    Zhang CL; Yu LZ; Gu FL; Buka SD; Zu SL; Xie SS; Pan ZY
    Urol Res; 1998; 26(5):343-8. PubMed ID: 9840344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.
    Bamias A; Keane P; Krausz T; Williams G; Epenetos AA
    Cancer Res; 1991 Jan; 51(2):724-8. PubMed ID: 1985790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.
    Feneley MR; Chengazi VU; Kirby RS; Nimmon CC; Granowska M; Mather SJ; Ellison D; Granowski AR; Britton KE
    Br J Urol; 1996 Mar; 77(3):373-81. PubMed ID: 8814841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.